Market Research Report

Human Albumin Injection Market, Global Outlook and Forecast 2023-2029

  • AMR ID : 7-11605
  • CAT ID : 7
  • Pages : 114
  • Date : Jun 2023
 

The global Human Albumin Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Blood Extraction Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Albumin Injection include Octapharma, CSL Behring, Biotest (UK) Ltd, Baxter, Kedrion Biopharma, Inc., Grifols, GE HealthCare, Bio Products Laboratory and Green Cross, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Human albumin solutions are used in a range of medical and surgical problems.
This report aims to provide a comprehensive presentation of the global market for Human Albumin Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Albumin Injection. This report contains market size and forecasts of Human Albumin Injection in global, including the following market information:
Global Human Albumin Injection Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Human Albumin Injection Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Human Albumin Injection companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Albumin Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Albumin Injection Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Albumin Injection Market Segment Percentages, by Type, 2022 (%)
Blood Extraction
Recombine
Global Human Albumin Injection Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Albumin Injection Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global Human Albumin Injection Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Albumin Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Albumin Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Albumin Injection revenues share in global market, 2022 (%)
Key companies Human Albumin Injection sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Human Albumin Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Octapharma
CSL Behring
Biotest (UK) Ltd
Baxter
Kedrion Biopharma, Inc.
Grifols
GE HealthCare
Bio Products Laboratory
Green Cross
SK Plasma
Instituto Grifols
Takeda
Hualan Bio
Nanyue Biopharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Albumin Injection, market overview.
Chapter 2: Global Human Albumin Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Human Albumin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Albumin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Albumin Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
1.1 Human Albumin Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Albumin Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Albumin Injection Overall Market Size
2.1 Global Human Albumin Injection Market Size: 2022 VS 2029
2.2 Global Human Albumin Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Human Albumin Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Human Albumin Injection Players in Global Market
3.2 Top Global Human Albumin Injection Companies Ranked by Revenue
3.3 Global Human Albumin Injection Revenue by Companies
3.4 Global Human Albumin Injection Sales by Companies
3.5 Global Human Albumin Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Albumin Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Albumin Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Albumin Injection Players in Global Market
3.8.1 List of Global Tier 1 Human Albumin Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Albumin Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Albumin Injection Market Size Markets, 2022 & 2029
4.1.2 Blood Extraction
4.1.3 Recombine
4.2 By Type - Global Human Albumin Injection Revenue & Forecasts
4.2.1 By Type - Global Human Albumin Injection Revenue, 2018-2023
4.2.2 By Type - Global Human Albumin Injection Revenue, 2024-2029
4.2.3 By Type - Global Human Albumin Injection Revenue Market Share, 2018-2029
4.3 By Type - Global Human Albumin Injection Sales & Forecasts
4.3.1 By Type - Global Human Albumin Injection Sales, 2018-2023
4.3.2 By Type - Global Human Albumin Injection Sales, 2024-2029
4.3.3 By Type - Global Human Albumin Injection Sales Market Share, 2018-2029
4.4 By Type - Global Human Albumin Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Albumin Injection Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Human Albumin Injection Revenue & Forecasts
5.2.1 By Application - Global Human Albumin Injection Revenue, 2018-2023
5.2.2 By Application - Global Human Albumin Injection Revenue, 2024-2029
5.2.3 By Application - Global Human Albumin Injection Revenue Market Share, 2018-2029
5.3 By Application - Global Human Albumin Injection Sales & Forecasts
5.3.1 By Application - Global Human Albumin Injection Sales, 2018-2023
5.3.2 By Application - Global Human Albumin Injection Sales, 2024-2029
5.3.3 By Application - Global Human Albumin Injection Sales Market Share, 2018-2029
5.4 By Application - Global Human Albumin Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Human Albumin Injection Market Size, 2022 & 2029
6.2 By Region - Global Human Albumin Injection Revenue & Forecasts
6.2.1 By Region - Global Human Albumin Injection Revenue, 2018-2023
6.2.2 By Region - Global Human Albumin Injection Revenue, 2024-2029
6.2.3 By Region - Global Human Albumin Injection Revenue Market Share, 2018-2029
6.3 By Region - Global Human Albumin Injection Sales & Forecasts
6.3.1 By Region - Global Human Albumin Injection Sales, 2018-2023
6.3.2 By Region - Global Human Albumin Injection Sales, 2024-2029
6.3.3 By Region - Global Human Albumin Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Human Albumin Injection Revenue, 2018-2029
6.4.2 By Country - North America Human Albumin Injection Sales, 2018-2029
6.4.3 US Human Albumin Injection Market Size, 2018-2029
6.4.4 Canada Human Albumin Injection Market Size, 2018-2029
6.4.5 Mexico Human Albumin Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Human Albumin Injection Revenue, 2018-2029
6.5.2 By Country - Europe Human Albumin Injection Sales, 2018-2029
6.5.3 Germany Human Albumin Injection Market Size, 2018-2029
6.5.4 France Human Albumin Injection Market Size, 2018-2029
6.5.5 U.K. Human Albumin Injection Market Size, 2018-2029
6.5.6 Italy Human Albumin Injection Market Size, 2018-2029
6.5.7 Russia Human Albumin Injection Market Size, 2018-2029
6.5.8 Nordic Countries Human Albumin Injection Market Size, 2018-2029
6.5.9 Benelux Human Albumin Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Human Albumin Injection Revenue, 2018-2029
6.6.2 By Region - Asia Human Albumin Injection Sales, 2018-2029
6.6.3 China Human Albumin Injection Market Size, 2018-2029
6.6.4 Japan Human Albumin Injection Market Size, 2018-2029
6.6.5 South Korea Human Albumin Injection Market Size, 2018-2029
6.6.6 Southeast Asia Human Albumin Injection Market Size, 2018-2029
6.6.7 India Human Albumin Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Human Albumin Injection Revenue, 2018-2029
6.7.2 By Country - South America Human Albumin Injection Sales, 2018-2029
6.7.3 Brazil Human Albumin Injection Market Size, 2018-2029
6.7.4 Argentina Human Albumin Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Albumin Injection Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Human Albumin Injection Sales, 2018-2029
6.8.3 Turkey Human Albumin Injection Market Size, 2018-2029
6.8.4 Israel Human Albumin Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Human Albumin Injection Market Size, 2018-2029
6.8.6 UAE Human Albumin Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Octapharma
7.1.1 Octapharma Company Summary
7.1.2 Octapharma Business Overview
7.1.3 Octapharma Human Albumin Injection Major Product Offerings
7.1.4 Octapharma Human Albumin Injection Sales and Revenue in Global (2018-2023)
7.1.5 Octapharma Key News & Latest Developments
7.2 CSL Behring
7.2.1 CSL Behring Company Summary
7.2.2 CSL Behring Business Overview
7.2.3 CSL Behring Human Albumin Injection Major Product Offerings
7.2.4 CSL Behring Human Albumin Injection Sales and Revenue in Global (2018-2023)
7.2.5 CSL Behring Key News & Latest Developments
7.3 Biotest (UK) Ltd
7.3.1 Biotest (UK) Ltd Company Summary
7.3.2 Biotest (UK) Ltd Business Overview
7.3.3 Biotest (UK) Ltd Human Albumin Injection Major Product Offerings
7.3.4 Biotest (UK) Ltd Human Albumin Injection Sales and Revenue in Global (2018-2023)
7.3.5 Biotest (UK) Ltd Key News & Latest Developments
7.4 Baxter
7.4.1 Baxter Company Summary
7.4.2 Baxter Business Overview
7.4.3 Baxter Human Albumin Injection Major Product Offerings
7.4.4 Baxter Human Albumin Injection Sales and Revenue in Global (2018-2023)
7.4.5 Baxter Key News & Latest Developments
7.5 Kedrion Biopharma, Inc.
7.5.1 Kedrion Biopharma, Inc. Company Summary
7.5.2 Kedrion Biopharma, Inc. Business Overview
7.5.3 Kedrion Biopharma, Inc. Human Albumin Injection Major Product Offerings
7.5.4 Kedrion Biopharma, Inc. Human Albumin Injection Sales and Revenue in Global (2018-2023)
7.5.5 Kedrion Biopharma, Inc. Key News & Latest Developments
7.6 Grifols
7.6.1 Grifols Company Summary
7.6.2 Grifols Business Overview
7.6.3 Grifols Human Albumin Injection Major Product Offerings
7.6.4 Grifols Human Albumin Injection Sales and Revenue in Global (2018-2023)
7.6.5 Grifols Key News & Latest Developments
7.7 GE HealthCare
7.7.1 GE HealthCare Company Summary
7.7.2 GE HealthCare Business Overview
7.7.3 GE HealthCare Human Albumin Injection Major Product Offerings
7.7.4 GE HealthCare Human Albumin Injection Sales and Revenue in Global (2018-2023)
7.7.5 GE HealthCare Key News & Latest Developments
7.8 Bio Products Laboratory
7.8.1 Bio Products Laboratory Company Summary
7.8.2 Bio Products Laboratory Business Overview
7.8.3 Bio Products Laboratory Human Albumin Injection Major Product Offerings
7.8.4 Bio Products Laboratory Human Albumin Injection Sales and Revenue in Global (2018-2023)
7.8.5 Bio Products Laboratory Key News & Latest Developments
7.9 Green Cross
7.9.1 Green Cross Company Summary
7.9.2 Green Cross Business Overview
7.9.3 Green Cross Human Albumin Injection Major Product Offerings
7.9.4 Green Cross Human Albumin Injection Sales and Revenue in Global (2018-2023)
7.9.5 Green Cross Key News & Latest Developments
7.10 SK Plasma
7.10.1 SK Plasma Company Summary
7.10.2 SK Plasma Business Overview
7.10.3 SK Plasma Human Albumin Injection Major Product Offerings
7.10.4 SK Plasma Human Albumin Injection Sales and Revenue in Global (2018-2023)
7.10.5 SK Plasma Key News & Latest Developments
7.11 Instituto Grifols
7.11.1 Instituto Grifols Company Summary
7.11.2 Instituto Grifols Human Albumin Injection Business Overview
7.11.3 Instituto Grifols Human Albumin Injection Major Product Offerings
7.11.4 Instituto Grifols Human Albumin Injection Sales and Revenue in Global (2018-2023)
7.11.5 Instituto Grifols Key News & Latest Developments
7.12 Takeda
7.12.1 Takeda Company Summary
7.12.2 Takeda Human Albumin Injection Business Overview
7.12.3 Takeda Human Albumin Injection Major Product Offerings
7.12.4 Takeda Human Albumin Injection Sales and Revenue in Global (2018-2023)
7.12.5 Takeda Key News & Latest Developments
7.13 Hualan Bio
7.13.1 Hualan Bio Company Summary
7.13.2 Hualan Bio Human Albumin Injection Business Overview
7.13.3 Hualan Bio Human Albumin Injection Major Product Offerings
7.13.4 Hualan Bio Human Albumin Injection Sales and Revenue in Global (2018-2023)
7.13.5 Hualan Bio Key News & Latest Developments
7.14 Nanyue Biopharmaceuticals
7.14.1 Nanyue Biopharmaceuticals Company Summary
7.14.2 Nanyue Biopharmaceuticals Business Overview
7.14.3 Nanyue Biopharmaceuticals Human Albumin Injection Major Product Offerings
7.14.4 Nanyue Biopharmaceuticals Human Albumin Injection Sales and Revenue in Global (2018-2023)
7.14.5 Nanyue Biopharmaceuticals Key News & Latest Developments
8 Global Human Albumin Injection Production Capacity, Analysis
8.1 Global Human Albumin Injection Production Capacity, 2018-2029
8.2 Human Albumin Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Albumin Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Albumin Injection Supply Chain Analysis
10.1 Human Albumin Injection Industry Value Chain
10.2 Human Albumin Injection Upstream Market
10.3 Human Albumin Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Albumin Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

 
Choose License Type

Single User : $3250


Corporate User : $4225


Why Choose Us ?

24/7 Research support

Quality assurance

Information security

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe